MOD GRF 1-29 (10 MG X 10 VIALS)

Mod GRF 1-29

Description

Mod GRF 1-29 is a peptide hormone (also known as a protein hormone) that was

developed in Canada and first mentioned in medical literature in 2005. It is a protein

that is 29 amino acids long and is a GHRH analogue. As a GHRH analogue, Mod

GRF 1-29 (CJC-1295 without DAC) acts on receptors at the pituitary gland to

stimulate the release of Human Growth Hormone. Mod GRF 1-29 acts upon

receptors located in the anterior pituitary gland, and signals the pituitary gland to

increase Human Growth Hormone production and cause a release of massive

quantities of Human Growth Hormone in a pulsatile manner. The effects of Mod GRF

1-29 are very similar from what would be expected from synthetic HGH

administration over the long term (see the Human Growth Hormone profile here),

although the amount of time that the released human growth hormone will remain in

circulation is of a far less amount of time than synthetic Human Growth Hormone

does. Therefore, multiple applications of Mod GRF 1-29 is recommended

throughout the day in order to simulate Human Growth Hormone levels that remain

high on a constant basis. Mod GRF 1-29 (CJC-1295 without DAC) is commonly

combined with a Ghrelin mimetic (also known as a GHRP — Growth Hormone

Releasing Hexapeptide), such as GHRP-6, GHRP-2, Hexarelin, or Ipamorelin in

order to initiate and amplify a greater pulse of HGH from the pituitary compared to

Mod GRF 1-29 used solitarily on its own. The effects of a GHRH analogue (such as

Mod GRF 1-29) and a Ghrelin mimetic (a GHRP such as GHRP-6 or Ipamorelin) are

synergistic and amplify the release of HGH.

Mod GRF 1-29 is a sterile, non-pyrogenic, white lyophilized powder intended for

subcutaneous or intramuscular injection, after reconstitution with sterile Water for

Injection.

Mechanism of Action

As a result Mod GRF 1-29 Therapy, the increased volume of human growth

hormone (hGH) secreted by the stimulated pituitary gland is converted by the liver

into IGF-1. The increased amount of IGF-1 in the bloodstream results an increase in

metabolism and growth of new cells within the body’s organs and bones. This

treatment is prescribed for unlabeled use in adults to increase lean muscle mass,

reduce body fat, increase bone density, enhance the immune system, and

strengthen the heart, as well as, other organs of the body. Since the increased

volume of human growth hormone is produced by the body’s pituitary gland, the

body’s endocrine system will not allow more growth hormone to be produced by the

Mod GRF 1-29 stimulation of the pituitary than the body can safely process within

the endocrine self-monitoring system.

Positive results of Mod GRF 1-29 is very similar to recombinant human

growth hormone therapy results:

• Increases the development of lean body mass through the

development of new muscle cells

• Reduces body fat through lipolysis
• Increases energy and vitality
• Increases strength
• Increases endurance
• Accelerates healing from wounds or surgery
• Strengthens the heart
• Enhances the immune system
• Increases IGF-1 production
• Improves sleep quality
• Increases calcium retention, and strengthens and increases the

mineralization of bone or bone density.

• Increases protein synthesis and stimulates the growth of all internal

organs except the brain.

Adverse reactions

Hexarelin is generally very well tolerated by most individuals when used at the

recommended doses of up to 200mcg per injection.

• Hives
• Temporary Redness of Face and Neck
• Difficulty Swallowing
• Head Pain
• Dizzy
• Nervous

Instructions for reconstitution

Flip off the top of the peptide vial with your thumb. Use the alcohol swab to wipe the

rubber stopper of the peptide vial. Push the needle of the syringe into the middle of the

rubber stopper so it goes through the rubber and into the vial. Now, while angling the

needle so that the water for injection goes down the side of the glass, rather than

directly into the powder, inject the water for injection into the vial. Repeat this step until

you have the correct amount of water in the vial. The powder will dissolve quickly,

however it can help to gently roll the vial in between your fingers (do not shake the vial

vigorously). Remove the syringe and dispose of it. You should never reuse a syringe.

Dosage

Recommended dosage of Mod GRF 1-29:

•  200 — 500 mg once per day.

Storage

• After reconstitution, may be stored for a maximum of 14 days in a refrigerator at 2°C — 8°C.
• Store vials in an upright position.
• Store in a refrigerator (2°C — 8°C). Keep in the outer carton in order to protect from light.
• For one month can be stored at room temperature.